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Introduction. Reducing smoking during pregnancy is a public health priority. Nicotine
replacement therapy (NRT) is offered routinely to pregnant women who smoke in the
United Kingdom. However, evidence of treatment efficacy in this population is weak,
most likely due to poor adherence. Guided by the Necessity-Concerns Framework, we
conducted a qualitative study to better understand pregnant women’s perceived needs
and concerns regarding NRT use, with consideration of combination NRT.
Methods. Semi-structured interviews were conducted by telephone with 18 pregnant
or recently pregnant women in England and Wales, purposively sampled for different
NRT-related experiences. Participants were recruited online via Facebook adverts and
through a Stop Smoking Service. A hybrid approach of deductive and inductive thematic
coding was used for analysis.
Results. Findingswere organized around three themes: 1) the role ofmotivation to stop
smoking; 2) necessity beliefs about usingNRT; and 3) concerns aboutNRT. Somewomen
reported fluctuating motivation for stopping smoking which undermined their NRT use.
Others used NRT to cut down the number of cigarettes they smoked. Reasons for low
NRT necessity beliefs included a preference for quitting unassisted, low or unrealistic
expectations of efficacy, and overconfidence in achieving cessation (necessity testing).
Concerns included safety, particularly around increased nicotine exposure with
combination NRT, addictiveness, side effects, and capability to use.
Conclusion. Pregnant women have multiple necessity beliefs and concerns that
influence their use of NRT. Targeting these, alongside increasing and maintaining
motivation to quit smoking, will likely help optimize NRT use in pregnancy and improve
quit rates.
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Statement of contribution
What is already known on this subject?
 Smoking during pregnancy is the largest avoidable cause of negative health outcomes for mothers
and babies. Nicotine replacement therapy (NRT) is an effective cessation aid in the general
population. However, there is uncertainty about whether it helps pregnant women to quit. One
likely reason for this is that pregnantwomendonot adhere to treatment,meaning they use too little
NRT or stop earlier than recommended. Qualitative methods can enable deeper understanding of
the factors that influence pregnant women’s adherence to NRT.
What does the study add?
 A theoretically informed understanding of pregnant women’s adherence-related beliefs and
concerns about using NRT for smoking cessation.
 Insight into the complex concerns pregnant women have about using combination NRT.
 Support for the theoretical predictions of the Necessity-Concerns Framework in that necessity
beliefs and concerns are important factors in adherence to NRT in pregnancy; this can be used to
develop interventions that target these determinates more effectively.
 Highlights the importance of sustaining motivation to quit smoking in enabling better NRT
adherence in pregnancy.
Background
Smoking in pregnancy is the leading modifiable cause of adverse pregnancy and perinatal
outcomes (Cnattingius, 2004). Globally, large numbers of pregnant women smoke, with
rates highest in Europe and the Americas (Lange, Probst, Rehm, & Popova, 2018). In
England, it is estimated that around one in ten women smoke during pregnancy (NHS
Digital, 2019). Many women quit smoking in the first few days after discovering they are
pregnant (Heil et al., 2014; Solomon & Quinn, 2004), with almost half ‘spontaneously
quitting’ before their first antenatal appointment (Hotham, Ali, White & Robinson, 2008).
However, those who continue to smoke are often more dependent on nicotine (Riaz,
Lewis, Naughton, & Ussher, 2018) and so find it particularly hard to quit.
Nicotine replacement therapy (NRT) is recommended in the current National Institute
for Clinical Excellence and Health (NICE) guidance for pregnant women in England who
are unable to quit smoking unassisted (NICE, 2010). However, while there is high-quality
evidence that NRT is an effective cessation treatment in the general population
(Hartmann-Boyce, Chepkin, Ye, Bullen, & Lancaster, 2018), evidence for NRT efficacy
in pregnancy is less strong (Claire et al, 2020). In trials enrolling pregnant smokers, those
with comparable data revealed that only 7% to 29% reported finishing prescribed NRT
courses (Claire et al, 2020). One explanation for this is poor treatment adherence,
meaning that pregnant women do not use enough NRT, use it incorrectly, or stop
treatment prematurely. Increased nicotine metabolism in pregnancy, which might make
the dose of nicotine inNRT less effective at ameliorating cravings, may partly help explain
this poor adherence (Bowker, Lewis, Coleman, & Cooper, 2015; Dempsey, Jacob, &
Benowitz, 2002).
Expert opinion is that using NRT in pregnancy is much safer than continuing to smoke
(Bar-Zeev, Lim, Bonevski, Gruppetta, & Gould, 2018; Claire et al, 2020) and, in England, it
is standard practice to offer combination NRT (i.e., a nicotine patch combined with a fast-
acting NRT product, such as the nicotine gum, inhalator, or lozenges). A recent survey in
England found that 86% of smoking cessation services offered combination NRT in
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pregnancy (Cooper et al., 2019). Evidence amongnon-pregnant smokers shows that using
combination NRT has greater efficacy than a single NRT product (Lindson et al., 2019).
Combination NRT may be particularly helpful for pregnant women given their increased
nicotine metabolism. One observational study has found that use of combination NRT in
pregnancy can increase the chances of successfully stopping smoking (Brose, McEwen, &
West, 2013); however, further evidence of the incremental benefit of using combination
NRT in pregnancy from randomized trials is needed.
The reasons why pregnant women do not use NRT as instructed are not fully
understood. Quantitative research primarily provides contextual data (Fish et al., 2009;
Hotham, Gilbert, & Atkinson, 2006; Ussher & West, 2003; Vaz et al., 2016). The few
qualitative studies which have explored women’s perceptions and behaviour related to
NRT have highlighted that expectations around the use of NRT, safety concerns, and the
experience of side effects are all potential issues (Ashwin & Watts, 2010; Bowker et al.,
2016). Additionally, pregnant women often use NRT in ineffective ways based on their
fears about nicotine (Bowker et al., 2016). However, none of these studies characterize
findings using theory to understand the likely process of behaviour change, which is
considered an integral step in the development of complex interventions (Craig et al.,
2008).Nor do they considerwomen’s concerns andbeliefs about using combinationNRT.
Theory-informed evidence is needed to advance our understanding of NRT use in
pregnancy and to guide interventions aimed at improving adherence. The present study
draws on the Necessity-Concerns Framework (NCF) (Horne et al., 2013; Horne &
Weinman, 1999; Phillips, Diefenbach, Kronish, Negron, &Horowitz, 2014) to understand
pregnant women’s NRT adherence-related beliefs, with consideration of combination
NRT. This framework proposes that an individual’s adherence to prescribedmedication is
dependent on the relationship between two dimensions: beliefs about need for treatment
(necessity beliefs) and concerns about using the treatment. If perceived need to use the
medicationoutweighs concerns, then adherence ismore likely.Wechose to focus onhow
individual-level factors (i.e., cognitions and perceptions) might affect adherence to NRT
since they are typically modifiable and therefore are most suited to targeting in behaviour
change interventions.
Methods
Design
The research forms part of a multi-phase programme to develop and test a behavioural
intervention to encourage pregnant women’s adherence to combination NRT for
smoking cessation, to ultimately be used in UK NHS Stop Smoking Service (SSS) support
(Thomson et al., 2018). Thepresent study involved semi-structured telephone interviews.
Ethical approval was obtained from the National Health Service (NHS) Ethics Committee
(12/EM/0388). The manuscript follows the Consolidated Criteria for Reporting Qualita-
tive Research (COREQ) guidelines (Tong, Sainsbury, & Craig, 2007).
Sampling and recruitment
A purposive sampling frame was developed to ensure inclusion of four different NRT-
related experiences: having been offered NRT but not accepted it; accepted NRT but
discontinued use prematurely; accepted NRT but concurrently smoked, or relapsed to
smoking; and used/using NRT successfully. These categories were chosen in order to
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provide insight into pregnant women’s decisions about whether or not to use NRT, along
with influences on both continued and optimal use. We recruited participants through
targeted Facebook adverts and a Stop Smoking Service. The Facebook adverts contained a
brief study description with an emphasis on the study being NHS research (see
Appendix S1). A maximum £15 daily advertising budget was set. When the advert was
clicked, women were redirected to an online registration form. Those who registered
interest in the studywere sent a participant information sheet electronically or bypost and
then contacted by telephone to have the study explained further. The total cost of
recruitment via Facebook was £377.00.
For the face-to-face recruitment, Stop Smoking Practitioners from a service in the East
Midlands region of England gave pregnant clients a participant information sheet and
explained the study. If the client was interested in taking part, their contact details were
securely sent to the first author to contact them. To take part in the study, women had to
be1) over 16 years old, 2) pregnant or have givenbirth in the last 6 months, 3) tried to quit
smokingwhile pregnant, 4) offeredNRT to help themquit (even if they decided not to use
it), and 5) an English speaker.
Eighteen participants were recruited from 66 women who had registered interest to
take part (15 out of 62 from the Facebook adverts, and 3 out of 4 from the SSS). Reasons for
non-participation were as follows: 1) not meeting eligibility criteria (11); 2) unable to
contact using details provided (20); 3) participant not answering for scheduled interview
or attempts to contact thereafter (9); and 4) reached data saturation for NRT-related
experience category (8). We attempted to ensure that we recruited a diverse sample
within each of the purposive categories and continued recruitment until we judged that
we had achieved data saturation, that is, no new issues or themes emerged.
Participant characteristics
Out of the eighteen participants (mean age: 30 years), 14 reported acceptingNRT in their
most recent pregnancy: Eight were offered combination NRT, with five accepting it
straight away and one accepting it after a week of using a single NRT product. The
remaining sixwho acceptedNRTbut had not been offered combinationNRThad typically
accessedNRT through aGPor hospitalmidwife. All participants recruited via the SSSwere
using NRT successfully, which is perhaps reflected in their continued engagement with
the service. Participants were White (17) or mixed ethnicity (1) and mostly from more
deprived backgrounds (12). Full participant characteristics are shown in Table 1.
Procedure
The interviews were conducted between April and August 2018 by LM (PhD) – a female
qualitative researcher who has undertaken formal training in interviewing skills and
qualitative data analysis. A flexible interview schedulewas developed by LMwith support
from the research team and our Public Involvement Advisory Panel (see Appendix S2).
This was guided by the NCF and explored participants’ smoking histories, their
perceptions of smoking in pregnancy, their concerns and necessity beliefs about using
NRT, any other issues influencing their engagement and adherence, and preferences for
support with using NRT. Participants were encouraged to talk at length and to raise issues
they felt were important. This resulted in new questions to elicit clarification and to
pursue emergent ideas raised by the participants, therefore reflecting an increased
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understanding of the problem. An example of this was teasing out differences in
perceptions between single versus combination NRT.
We obtained verbal consent at the beginning of the telephone interview and a hard
copywas sent to thewomen afterwards, alongwith a £20 high street shopping voucher as
a thank you for taking part. Interviews lasted 28–67 minutes, and were digitally recorded
and transcribed verbatim. A written summary and reflective notes were also produced.
Analysis
Weanalysed the interview transcripts using the principles of thematic analysis (TA); this is
a method for identifying and analysing common patterns (themes) within data (Braun &
Clarke, 2006) and is widely used in health research. To begin, reflective notes were
reviewed and transcripts carefully read for familiarization by LM. A hybrid coding
approach was then used to develop themes systematically: 1) theory-driven and prior
research-driven (deductive) and 2) data-driven (inductive) (Fereday & Muir-Cochrane,
Table 1. Participant characteristics
Recruited
Online (n = 15)
Recruited from
a Stop Smoking
Service (n = 3) All (n = 18)
n (%) n (%) n (%)
NRT experience
Offered – not accepted 4 (27) 0(0) 4 (22)
Accepted – accepted but discontinued 4 (27) 0(0) 4 (22)
Accepted – relapsed/restarted smoking 4 (27) 0(0) 4 (22)
Accepted – using/used successfully 3 (20) 3 (100) 6 (33)
Age
Under 25 years 4 (27) 0(0) 4 (22)
26 – 35 years 6 (40) 100 (3) 9 (50)
Over 35 years 5 (33) 0(0) 5 (28)
Ethnicity
White British 1 (7) 2 (67) 16 (89)
White others - 1 (33) 1 (6)
Mixed/multiple ethnic groups 1 (7) 0(0) 1 (6)
Pregnancy number
First pregnancy 4 (47) 1 (33) 8 (44)
Gestational age
First trimester (<14 weeks) 1 ( 7) 0(0) 1 (6)
Second trimester 14–27 weeks) 8 (47) 3 (100) 11 (61)
Third trimester (>27 weeks) 5 (33) 0(0) 5 (28)
Post-partum (≤6 month) 1 (7) 0(0) 1 (6)
IMD ranka
Less than median IMD rank 10 (67) 2 (67) 12 (67)
Past NRT use
Used NRT before (any time) 10 (67) 1 (33) 11 (61)
Used NRT in a previous pregnancy 3 (13) - 3 (17)
Offered combination NRT in pregnancy 5 (33) 3 (100) 8 (44)
Used combination NRT in pregnancy 4 (27) 2 (67) 6 (33)
Note. aEnglish Indices of Multiple Deprivation 2019 (Ministry of Housing Communities & Local
Government, 2019).
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2006). Initial deductive codeswere identified from the interview schedule and constructs
from the NCF (e.g., beliefs about smoking in pregnancy, beliefs about need to use NRT,
and concerns about takingNRT). Thiswas accompanied by amore exploratory approach,
whereby the interview transcripts were broadly coded for any data relevant to NRT
adherence. The codes were then grouped into themes, and this formed the basis for the
final thematic framework, which was refined and agreed through several iterations by LM
in discussion with RT and FN.
NVivo 11 software was used to sort the data into themes and subthemes. Case
classifications were assigned based on NRT-related experience to allow for comparison.
To ensure quality and rigour in the analytical process, the coding was independently
reviewed by RT (PhD) in order to establish consistency. We did not return transcripts to
participants for review, but our Public Involvement Advisory Panel was involved in the
interpretation of the data. This gave first-hand insight during this process and enabled us to
checkwhether the data resonatedwith their experiences (Birt, Scott, Cavers, Campbell, &
Walter, 2016). Constant comparison was used throughout the analysis and when
interpreting the findings in relation to other studies and relevant theory to help ensure
internal validity (Boeije, 2002). The analytical write-up was reviewed by all authors, who
are specialists in smoking cessation and behaviour change.
Results
The data describe women’s necessity beliefs and concerns in relation to using NRT for
smoking cessation in pregnancy. Representative quotations have been selected to
illustrate key findings and bring transparency to the qualitative analysis. The results are
presented under three main themes: 1) the role of motivation to stop smoking; 2)
necessity beliefs about using NRT; and 3) concerns about NRT – and 10 subthemes (see
Table 2). Quotes from participants are identified in the following manner: Participant 1
(P1), age, and NRT-related experience.
The role of motivation to stop smoking
Helpingwomen to quit smoking in pregnancy involves twoprocesses:motivating them to
quit and enabling them to stop once they try.We found that the consistency and drivers of
women’s motivation to stop smoking may influence their NRT use but, equally, NRT use
can potentially strengthen women’s desire to quit.
Table 2. Themes and subthemes
Theme Subthemes
The role of motivation to stop smoking Fluctuating motivation to stop smoking undermines NRT use
NRT use strengthening motivation to stop smoking
Necessity beliefs about using NRT Weighing up need for NRT
Expectations of NRT efficacy
Necessity testing
Concerns about NRT Safety in pregnancy
Combination NRT
Side effects
Dependency on NRT
Capability to use
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Fluctuating motivation to stop smoking undermines NRT use
The majority of interviewees tried to quit smoking once they found out they were
pregnant; a few tried to stop entirely but most started by cutting down the number of
cigarettes that they smoked. Somewomen had strong intrinsic motivation to quit, such as
beliefs about NRT harming their baby or concerns for their own health, which led them to
seek out cessation support proactively. Others were motivated by social influences and
the stigma associated with smoking in pregnancy. Conflict about quitting was common
and, despite recognizing that smoking in pregnancy was harmful and harbouring feelings
of guilt, a number of thewomen talked openly about the enjoyment value. In this context,
accepting NRT showed an initial motivation to stop smoking, but attitudinal ambivalence
or a lack of intrinsic motivation could undermine pregnant women’s NRT use and quit
attempts. This suggests that not allwomenwho acceptNRT aremotivated to quit smoking
or convinced NRT will help them.
I’ve tried nicotine replacements and, at theminute, it’s just notworking at all. But then I’mnot
sure if that’s because part ofmewants to and part of me doesn’t [. . .] If people are naggingme
togive upor saying ‘right, youneed to give up, youneed to do this’, yourmind’s not fully into it
because you don’t want to give up there and then. P1, 28yrs, started NRT but discontinued
Among those women who opted to use NRT, a few continued to smoke daily or on
occasion. Smoking was often triggered by life events and stressors, and it was apparent
that some women saw quitting as temporary. When they were struggling to use NRT or
not finding it effective, returning to smoking felt almost inevitable and this seemed to lead
them to think there was no point trying to stop.
I think I’m at the point now where I’m like ‘Oh well I might as well every now and then’
[smoke]. Because I know I probably will just go back to smoking once I’ve had the baby. P18,
24yrs, started NRT but discontinued
NRT use strengthening motivation to stop smoking
The relationship between motivation and NRT use was occasionally two-way; once a
woman had started using NRT, this could increase her motivation to want to quit.
Once I’d got the product I was quite eager to – I was a bit more enthusiastic and a bit more
eager to give it a try. And then when I didn’t like it, I thought well I’m going to go back for
something else because, you know, I was more like I want to do this thing more now, let’s try
this. P6, 39yrs, started NRT but discontinued
Necessity beliefs about using NRT
Generally, NRT was viewed positively by the women, even among those who did not
think it was right for them. Necessity beliefs to use NRT were closely aligned with
motivation to stop smoking but also incorporated other dimensions, such as weighing up
the need for NRT, expectations about the helpfulness of NRT, and overconfidence in
achieving cessation without it (necessity testing).
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Weighing up need for NRT
A number of the women had experienced difficulty quitting without NRT and described
needing something to ‘take the edge off’ their nicotine cravings. These women showed
strong necessity beliefs towards using NRT.
It was because I’d tried to cut down on my own and I was like crying and everything. I was
finding Iwas getting stressed out and things and I just couldn’t – I knew I needed something to
help us stop and I just couldn’t do it on my own. P12, 36yrs, using NRT relapsed/restarted
(including smoked alongside)
Those who believed that the effectiveness of NRT could be improved by using more
nicotine rather than less were more likely to be open to the idea of using combination
NRT:
I just thought the more the better really, like, if it’s going to stop me from smoking - I’ll try it!
P15, 26yrs, using/used NRT successfully
Contrary to this, some women thought it was better to quit without NRT, instead
preferring to use ‘just determination’. Typically, these women believed that quitting
unassisted was the most effective method, a perception which was often combined with
negative views about NRT. Perhaps more implicit in some explanations was a reluctance
to access help or wanting to take charge of quitting themselves without continuing
nicotine dependence. Yet sometimes it took a long time to quit thisway, especially if there
were setbacks due to nicotine withdrawal.
From what I understand it’s like the nicotine’s harmful as well [. . .] It made me think that for
me that if I just set a date it could be easier. And I tried to set a date a few times and then ended
up notworking, so I ended up slowly cutting down. P5, 17yrs, offeredNRTbut did not accept
it
Expectations of NRT efficacy
Women who had successfully used NRT in the past were more likely to want to use NRT
again, while reporting that NRT was helping with a current quit attempt helped to
reinforce necessity beliefs and encourage continued use.
You know cos I could literally feel myself not wanting nicotine, which was amazing - so that
made amassive difference, rather thanme seeming like I was constantly battling the cravings.
P7, 26yrs, using/used NRT successfully
However, when NRT had previously been ineffective or unpleasant, this could put
women off using it or choosing that particular product again.
I said I was pregnant, ‘do you smoke’, ‘yeah’, ‘do youwant to give up’, ‘yes I really would like
to’ - however, previously to being pregnant I had tried the patch. That didn’t work at all [. . .] it
just didn’t fulfil the craving. P3, 27yrs, offered NRT but did not accept it
The majority of women prioritized lay knowledge when evaluating whether or not to
use NRT: If NRT had worked for family members or friends, even if they were not
pregnant, this could persuade the women to give it try, whereas negative stories of failure
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or unpleasant side effects had the opposite effect. The quote below highlights how such
knowledgewas often conflicting and how awomanmay choose to listen towhatever best
aligns with her quitting and NRT intentions at the time.
I mean, she smoked quite a bit and she had them [nicotine patches] on all day at work and
she’d said that it sort of takes the edge off. So, yeah, that’swhy I tried them [. . .] but I didn’t use
them for a particularly long period of time. I thinkmyproblem is I hear things about things and
then it puts me off, like I heard that they give you funny dreams. P4, 33yrs, started NRT but
discontinued
A few women had unrealistic expectations of NRT and believed that it would make
quitting easy or that it would simulate the feeling of smoking. When they discovered this
was not the case, this could inhibit use.
I think I thought it would be quite easy, if you know what I mean? [. . .] like this magic thing
that’s just going to all of a sudden make me stop smoking. P6, 39yrs, started NRT but
discontinued
Necessity testing
Necessity beliefs about NRT were often dynamic and could change over time. Some
women stopped NRT prematurely because they had become overconfident and assumed
it was no longer needed. Other women had accidentally gone without NRT, and when
nicotine withdrawal or cravings appeared to be controlled, this would lead them to see
whether they could avoid smoking without it. In both these scenarios, the women were
testing their need for NRT – namely, ‘necessity testing’. However, stopping NRT too soon
could lead to relapse.
One day I forgot to put it on, but I didn’t want a cigarette, so I thought ‘oh I don’t need this
anymore’ but I was wrong. P11, 23yrs, using NRT relapsed/restarted (including smoked
alongside)
Concerns about NRT
Various concerns about using NRT in pregnancy were expressed, relating to safety, side
effects, addictiveness, and capability to use. For somewomen, these concerns intensified
in relation to using combination NRT.
Safety in pregnancy
WomenwhodeclinedNRT, discontinued use prematurely, orminimized their NRT intake
often had concerns about the effects of nicotine exposure during pregnancy. Some felt
that using any form of nicotine might increase the risk of health problems for their
developing baby, while a minority were uncertain about whether NRT could be used in
pregnancy. For some women, the negative image of nicotine was very apparent: ‘I guess
nicotine is still nicotine whatever you’re using’ (P3, 27yrs, offered NRT but did not
accept it). The majority of women, however, believed that NRT was less harmful to their
health than smoking, or at least nomore, but this perception still meant it camewith risks:
for example, that the addictive nature of nicotine still made it ‘harmful’ (see Dependence
on NRT).
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Often the womenweighed up the risks and benefits of using NRT; even if they did not
consider NRT to be completely safe, provided that it helped with cessation, it was seen as
preferable to smoking cigarettes.
I was a bit dubious to be honest to start with about using nicotine replacement, ‘cause
obviously, you’re still putting a chemical in your body which is still going to be absorbed by
your child. But I sort ofweighed it upwithmy partner andwe thoughtwell it’s better than the
alternative. P7, 26yrs, using/used NRT successfully
Some women had been advised by a health professional or Stop Smoking Practitioner
not to smoke and useNRT at the same time. This resulted in varied interpretations, such as
themdelaying using the nicotine patch in themorning or removing it temporarily in order
to have a cigarette.
At theweekend, I tend to go ‘I’ll just haveoneon amorning and then I’ll putmypatchon.’ P12,
36yrs, using NRT relapsed/restarted (including smoked alongside)
Two key aspects played a role inminimizing thewomen’s safety concerns: 1) that NRT
is prescribed on the NHS and has been for many years; and 2) evidence of safety and
effectiveness provided by health care practitioners.
I guess with something that the NHS is offering you, you know that surely that stuff’s been
tested and researched and there’s a lot more – you feel a lot more confidence I guess in that
respect that it’s safer. P4, 33yrs, started NRT discontinued
So like Iwas reallyworried that itwas going to harm the baby thatwasmymain concern but all
their research they gaveme and thenmy little bit of researchhelpedprove that it doesn’t affect
the baby. P9, 30yrs, using/used NRT successfully
Combination NRT
Some women worried about receiving more nicotine from NRT than they would have
done from cigarettes, while others expressed concerns about getting ‘too much nicotine’
from using two NRT products together and decided to only use one.
I don’t think I’d use both at the same time because itwould be toomuchwouldn’t it? [. . .] You
don’t knowwhat’s going to happenwith toomuch nicotine. P10, 43yrs, using NRT relapsed/
restarted (including smoked alongside)
A fewwomenweremorepositive about using twoproducts, especially if this helped to
reduce cigarette cravings and increase the likelihood of them quitting.
I was OK about that because I thought I’m going to be getting – she explained that I’d be
getting a constant feedwith the patch so thatwould helpwithmy cravings, but then if I had an
urge to have a cigarette, rather than have a cigarette have a [nicotine] mint, which has really
helped. P14, 31yrs, using/used NRT successfully
Side effects
Many of thewomen described a range of issues and side effects that they had experienced
and/or heard about fromothers. Not only did thewomen feel this could discourage others
from starting NRT, but it was also a common reason for not using NRT as instructed or
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discontinuing use. Some women appeared to confuse NRT side effects with nicotine
withdrawal or pregnancy-related symptoms, which led them to use less NRT or stop
altogether. One participant described howuseful it had been to have this explained by her
Stop Smoking Practitioner.
Yeah, the only thing I find in pregnancy, which was a bit tricky, is a lot of the NRT symptoms
are pregnancy symptoms, so I was a bit like is this a symptom from the pregnancy or from the
patch? So I think if that was explained to people as well, like, don’t panic, it might not
necessarily be the patch or your NRT, it could just be your pregnancy. And that was nice to
know because it was a bit reassuring. . . P14, 31yrs, using/used NRT successfully
Dependence on NRT
Some women expressed concerns about becoming addicted to NRT, in that they did not
see NRT use as ‘quitting’ but rather substituting one source of nicotine for another and
believed that they might be more likely to return to smoking post-partum.
Well I think, I feel like for me going from like cigarettes to nicotine replacement therapy
would just mean that I was still addicted to cigarettes, I was just finding another way to get
them. And then I feel like I’d bemore inclined then to start cigarettes again. P5, 17yrs, offered
NRT but did not accept it
With combination NRT, a few women minimized use of their fast-acting product
because they did not want to become dependent on it or increase their nicotine
dependence.
I don’twant to become reliant on it [gum], you know, like Iwould use it only in an emergency.
P8, 29yrs, using NRT relapsed/restarted (including smoked alongside)
Capability to use
Themajority of women in this study recalled being given clear instructions on how to use
NRT, particularly thosewhohad accessedNRT through a Stop Smoking Service. However,
some women were concerned about NRT dosage or the duration of treatment and so did
not use it properly. A fewwomen experienced practical issues using NRTwhich resulted
in them not using NRT regularly; for example, forgetting to put a patch on in the morning
or not having a short-acting product with them at all times.
I’m quite forgetful so I would just forget and kind of go back to smoking some days without
even thinking and then I’d be like ‘Oh I haven’t even used something today’. P18, 24yrs,
started NRT but discontinued
Setting up routines or reminders was one strategy used to overcome this. Concerns
about access to NRT to ensure an adequate supply, compared with the ease of access to
cigarettes, were also concerns for some women.
Discussion
This study highlights how women’s beliefs about needing NRT to quit smoking in
pregnancy and their concerns about using it might influence NRT adherence. The
qualitative research design has generated new insights into the types of necessity beliefs
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(quitting preferences, expectations of efficacy, and necessity testing) and concerns
(safety, addictiveness, side effects, and capability to use)which are particularly relevant to
pregnant women. These beliefs and attitudes seemed to intensify for combination NRT.
Thefindings also revealed thatNRTuse is at least in part explained bywomen’smotivation
to quit smoking.
To our knowledge, no other study has used the Necessity-Concerns Framework in the
context of smoking cessation in pregnancy. It has successfully been used to predict
medication non-adherence for a number of chronic diseases (Horne et al., 2013),whereby
people who are persuaded of the necessity of their medication and have their concerns
allayed are more likely to use their medication as directed. These cognitions are open to
influence, and any change in these beliefs can in turn lead to changes in adherence (Sch€uz
et al., 2011). Unlikemany diseases or conditions, however, smoking is a behaviour which
provides physical and psychological rewards despite its harmful consequences.
Moreover, people can be physically or emotionally dependent on cigarettes and many
link smokingwith certain activities,making the habit hard to break. Consistentmotivation
to stop smoking has therefore been suggested as a key variable in driving and sustaining
attempts to quit (Perski, Herd, Brown, & West, 2018). Our findings highlight that this is
likely connected with NRT adherence too; even when the pregnant women accepted
NRT and appeared generally motivated to quit, sometimes their motivation was in flux,
which could undermine NRT use. This was particularly apparent for women who
appeared to accept NRT because of the pressure to stop smoking (i.e., extrinsic
motivation) rather than the decision coming from within themselves (i.e., intrinsic
motivation); this issue is particularly relevant for pregnant women. This finding supports
research on the importance of intrinsic motivation for smoking cessation in pregnancy
(Curry, McBride, Grothaus, Lando, & Pirie, 2001) and suggests that continued emphasis
on the benefits of smoking cessation could indirectly facilitate adherence to NRT.
The fact that somepregnantwomencontinued to smokewhile usingNRTpoints to the
fact that knowledge of the smoking health risks alone is rarely enough to contribute to
behaviour change. In a previous study, Bowker et al reported thatmanywomenusedNRT
to cut down the number of cigarettes they smoked rather than to stop smoking (Bowker
et al., 2016). We similarly found that some women were not ready to give up smoking,
while others had planned to quit but found NRT did not sufficiently ameliorate cigarette
cravings or lacked the necessary willpower to quit smoking. Most notably, there were
women who had been advised not to smoke and use NRT at the same time, resulting in
them delaying use or temporarily stopping NRT in order to smoke. This is perhaps an
example of where precautionary or inconsistent approaches by health care professionals
could be compromising the effectiveness of a treatment.
This study identified a number of modifiable beliefs and concerns that could be
targeted at an individual level to promote better use of NRT in pregnancy. For example,
increasing confidence inNRT as a quitting aid or alleviating concerns aboutNRT addiction
could facilitatewomen’s initiation and continued use of NRT. In an effort tomake sense of
what can often be conflicting advice about how best to quit smoking in pregnancy
(Herberts & Sykes, 2012), the women often made their own common-sense judgements,
seemingly giving preference to personal observation over professional or evidence-based
knowledge when it came to usage and efficacy. This concept is known as ‘lay
epidemiology’ (Davison, Smith, & Frankel, 1991) and has previously been used as a way
to explain why some initiatives designed to reduce smoking fail (Lawlor, Frankel, Shaw,
Ebrahim, & Smith, 2003). Efforts to improve adherence to NRT in pregnancy may require
further consideration of appropriate sources for different information, making evidence-
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based information readily available and perhaps involving real-life testimonies or peer
support to promote cessation as a way to engage with these lay knowledge values.
We also found that some women were keen to try stopping NRT prematurely if they
thought they might no longer need it (necessity testing). Although not expressed
explicitly, it seems likely that necessity testingmight be intensified by a desire tominimize
medication use in pregnancy. This mimics women’s cessation of other prescription drugs
during pregnancy without consulting health care professionals, for example asthma
inhalers (Enriquez et al., 2006) and antiepileptic drugs (Williams et al., 2002). Health care
practitioners should encourage women to use NRT for the recommended 8-12 weeks
minimum, regardless of whether they feel like they need to use it. Establishing realistic
expectations of what NRT can and cannot do might also reduce any frustrations or
disappointment that can lead to its early discontinuation.
Many of the concerns raised about using NRT are similar to those found in previous
studies, which have suggested some women believe that NRT might cause harm to their
baby or increase their nicotine intake and dependence (Ashwin & Watts, 2010; Bowker
et al., 2016). Importantly, we found that some women reported heightened harm
concerns when it came to using combination NRT in relation to getting ‘too much
nicotine’ or more nicotine than they would otherwise have got from cigarettes. Such
beliefs often endured despite knowledge that nicotine was not the harmful substance in
cigarettes, arguably because of fears about increasing nicotine dependence or greater
doses of nicotine being delivered to their unborn baby. However, NRT delivers a lower
nicotine dose than smoking (Hickson et al., 2019); RCTs have shown no demonstrable
harm fromNRT (Claire et al., 2020) and the only RCT of NRT in pregnancy to report infant
outcomes found better infant development at two years of age in those whose mothers
used active NRT in pregnancy compared to a placebo (Cooper et al., 2014). Interventions
aimed at increasing adherence to NRT in pregnancy must recognize that women have
specific concerns about using combination NRT and that these concerns are often
multifaceted.
The findings showed that some women had practical concerns, such as remembering
to useNRT, that could lead to unintentional non-adherence,whilewomen’s confidence in
their knowledge of how to use NRT could also impact on its use. Research looking at NRT
adherence in the general population found that a lack of procedural knowledge about
NRT was likely to result in avoidable side effects and reduced effectiveness (Herbec,
Tombor, Shahab, & West, 2018). Given that side effects or other product issues were
reported to make it difficult to continue NRT use, it is important to help women manage
these issues and be able to distinguish between NRT side effects and nicotine withdrawal
symptoms as the latter may signal that more NRT is needed.
Recognizing the challenges in supporting pregnant women to stop smoking, the UK
National Centre for Smoking Cessation and Training (NCSCT) recently updated its
‘Standard Treatment Programme for Pregnant Women’ which now encourages Stop
Smoking Practitioners to address misunderstandings about the safety of NRT and its
importance in helping pregnant women to quit. However, there are still a number of
opportunities to optimize NRT support, including specific messages to address women’s
common concerns and suboptimal usage.
Implications for future intervention development
The study identified a range of opportunities to enhance adherence to NRT in pregnancy
which could be addressed as part of an intervention. These are summarized in Box 1.
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Box 1Implications of findings for future intervention development
 Even when women accept NRT and appear motivated to quit, ambivalence and
uncertainties about stopping smoking can undermine NRT use. Continued focus on
the negative health effects of smoking and enabling women to relate these to their
personal situations therefore need to accompany NRT-specific support. Moreover,
provision of NRT should be accompanied by an exploration about women’s
motivation, beliefs, and concerns irrespective of how readily they accept it.
 Women often smoke alongside using NRT, but advice about this is currently
inconsistent and confusing. Education around the dangers of smoking any amount
during pregnancy is needed, along with clear and consistent advice about howNRT
should be used during a smoking slip or longer lapse.
 Somewomenhad lowexpectations of the benefit ofNRT, either because of personal
experience orword ofmouth. Discussing the reasonswhyNRTmight not have been
effective previously or for others (e.g., increased nicotine metabolism in pregnancy
and the importance of following the recommended regime), along with promoting
positive real-life testimonies, might encourage women to start and continue with
NRT.Women should be strongly advised to use combination NRT from the start and
explained why.
 Anxieties about NRT safety and nicotine exposure can inhibit use, especially in the
case of combinationNRT. Anumber of steps can be taken to address these concerns:
1) reinforce that NRT is licensed for use in pregnancy and prescribed by the NHS, 2)
explore and give women opportunity to discuss any concerns they might have, and
3) ensure that health professionals provide womenwith consistent, evidence-based
information on the safety and effectiveness of NRT.
 Somewomen felt that NRTwas another potentially addictive substance or that they
might increase their nicotine dependence by taking higher NRT doses or
combination NRT. This is unlikely, given that the nicotine in NRT is delivered to the
brain much more slowly than when smoking. The fact that NRT very rarely leads to
dependence needs to be reinforced when NRT is provided.
 Remembering to use NRT regularly was an issue for some women. Encouraging
women to set up routines and reminders, along with providing extra supplies of
short-acting products so that they can have it with them at all times, might help to
address this unintentional non-adherence.
 Equipping pregnant women with the right knowledge about their recommended
NRT regime, especially combination NRT, is essential; otherwise, they may use it
incorrectly and not get the maximum benefit. Moreover, women should be told
upfront to use NRT for a minimum of 8-12 weeks but also that it can be used
throughout pregnancy if needed.
 Side effects and other issues were a key reason for NRT discontinuation. Managing
expectations about side effects, providing tips for dealing with them, and helping
women to distinguish between nicotine withdrawal, pregnancy-related symptoms,
and NRT side effects could help women to continue using NRT.
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Strengths and limitations
A key strength is that this was a theory-informed qualitative study using the NCF, which
can support health care professionals in targeting beliefs that form the basis of patients’
attitudes about theirmedication anddecisions onwhether or not to take it. Bothdeductive
and inductive codingwere used for the analysis. This enabled us to examine the relevance
of existing theory but also to identify new ideas emerging from the data. The recruitment
method both ensured good representation from low socio-economic groups who are less
likely to take part in research, and also reachedwomenwhomight be disengaged from SSS
(i.e., those who had not accepted NRT and those who had stopped using it). Indeed,
compared to women recruited via Facebook, those recruited via the SSS all had ongoing
engagement with the service which suggests that they were motivated towards quitting
smoking and using NRT.
The main limitation of this study is that it only reports on individual-level barriers to
adherence, and it is well recognized that some of the barriers tomedication adherence are
external to the patient, such as social support and health care system factors (Osterberg&
Blaschke, 2005). There was also a reliance on telephone, rather than face-to-face
interviews. This latter is a feature of the fact that pregnant womenwho smoke are hard to
reach in terms of research andwewanted to recruit from across England andWales.While
it is more challenging to develop rapport with participants over the phone, this approach
was found to be a good method when discussing topics of a potentially sensitive nature
(Sturges&Hanrahan, 2004). Participantswere primarily from aWhite British background,
and because the sampling frame was designed to reflect different NRT-related
experiences, there were small numbers within each group. Therefore, generalizations
from this study should bemadewith caution.Moreover,while it appeared that thewomen
received mixed support this was not directly observable by the researcher.
Conclusions
This study found that even when women are willing to accept NRT, their motivation to
quit smokingmay be in flux,which can undermine its use. Pregnantwomenhavemultiple
necessity beliefs and concerns that can positively or negatively influence use of NRT.
These beliefs and concerns often intensify for combination NRT, which is offered as
standard in England. Interventions to support optimal adherence to NRT in pregnant
women are likely to be more effective if they help to overcome these attitudinal and
informational barriers to NRT use, while amplifying positive beliefs about NRT. Further
research is required to identify optimal modalities for delivering support messages that
enhance pregnant women’s adherence to NRT.
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